Research and Markets: Congestive Heart Failure Pipeline Highlights Report 2014-2017

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/x9428d/congestive_heart) has announced the addition of the "Congestive Heart Failure Pipeline Highlights - 2015" report to their offering.

The latest report Congestive Heart Failure Pipeline Highlights - 2015, provides most up-to-date information on key pipeline molecules in the global Congestive Heart Failure market. It covers emerging therapies for Congestive Heart Failure in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Congestive Heart Failure pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Congestive Heart Failure pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Congestive Heart Failure pipeline molecules by the Originator Company.

Short-term Launch Highlights:

Find out which Congestive Heart Failure pipeline products will be launched in the US and Ex-US till 2017.

Key Topics Covered:

1. Congestive Heart Failure Pipeline by Stages

2. Congestive Heart Failure Pipeline by Drug Class

3. Congestive Heart Failure Pipeline by Company

4. Congestive Heart Failure Phase 3 Clinical Trial Insights

5. Congestive Heart Failure Phase 2 Clinical Trial Insights

6. Congestive Heart Failure Phase 1 Clinical Trial Insights

7. Congestive Heart Failure Preclinical Research Insights

8. Congestive Heart Failure Discovery Stage Insights

9. Appendix

10. Research Methodology

For more information visit http://www.researchandmarkets.com/research/x9428d/congestive_heart

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular